Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,200 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 June 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 183 pages)

 

Export 2252 results:
Author Title Type [ Year(Asc)]
2018
A. I. B. Kurdi, Elliott, R. A., and Chen, L. C., “Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors: a population-based study”, J Hypertens, 2018.
L. Li, Neogi, T., and Jick, S., “A cohort study of comorbidity in patients with granulomatosis with polyangiitis”, Rheumatology (Oxford), vol. 57, pp. 291-299, 2018.
J. Castellsague, Kuiper, J. G., Pottegard, A., I. Berglind, A., Dedman, D., Gutierrez, L., Calingaert, B., van Herk-Sukel, M. P., Hallas, J., Sundstrom, A., Gallagher, A. M., Kaye, J. A., Pardo, C., Rothman, K. J., and Perez-Gutthann, S., “A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study)”, Clin Epidemiol, vol. 10, pp. 299-310, 2018.
C. Schneider, Bodmer, M., Jick, S. S., and Meier, C. R., “Colorectal cancer and markers of anemia”, Eur J Cancer Prev, vol. 27, pp. 530-538, 2018.
J. Busby, Murray, L., Mills, K., Zhang, S. D., Liberante, F., and Cardwell, C. R., “A combined connectivity mapping and pharmacoepidemiology approach to identify existing medications with breast cancer causing or preventing properties”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 78-86, 2018.
S. Khalid, Calderon-Larranaga, S., Hawley, S., Ali, M. S., Judge, A., Arden, N., Van Staa, T., Cooper, C., Javaid, M. K., and Prieto-Alhambra, D., “Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database”, Clin Epidemiol, vol. 10, pp. 1417-1431, 2018.
L. Sinyavskaya, Gauthier, S., Renoux, C., Dell'Aniello, S., Suissa, S., and Brassard, P., “Comparative effect of statins on the risk of incident Alzheimer disease”, Neurology, vol. 90, pp. e179-e187, 2018.
S. Suissa, Dell'Aniello, S., and Ernst, P., “Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study”, Lancet Respir Med, vol. 6, pp. 855-862, 2018.
S. Y. Loo, Coulombe, J., Dell'Aniello, S., Brophy, J. M., Suissa, S., and Renoux, C., “Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study”, BMJ Open, vol. 8, p. e019638, 2018.
J. M. Gamble, Donnan, J. R., Chibrikov, E., Twells, L. K., Midodzi, W. K., and Majumdar, S. R., “Comparative Safety of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas and Other Glucose-lowering Therapies for Three Acute Outcomes”, Sci Rep, vol. 8, p. 15142, 2018.
C. S. Arhi, Bottle, A., Burns, E. M., Clarke, J. M., Aylin, P., Ziprin, P., and Darzi, A., “Comparison of cancer diagnosis recording between the Clinical Practice Research Datalink, Cancer Registry and Hospital Episodes Statistics”, Cancer Epidemiol, vol. 57, pp. 148-157, 2018.
J. L. Hong, Webster-Clark, M., Funk, M. J., Sturmer, T., Dempster, S., Cole, S. R., Herr, I., and LoCasale, R., “Comparison of Methods to Generalize Randomized Clinical Trial Results without Individual-Level Data for the Target Population”, Am J Epidemiol, 2018.
C. S. Arhi, Burns, E. M., Bouras, G., Aylin, P., Ziprin, P., and Darzi, A., “Complications after discharge and delays in adjuvant chemotherapy following colonic resection: a cohort study of linked primary and secondary care data”, Colorectal Dis, 2018.
K. M. Rhodes, Turner, R. M., Payne, R. A., and White, I. R., “Computationally efficient methods for fitting mixed models to electronic health records data”, Stat Med, vol. 37, pp. 4557-4570, 2018.
F. Nissen, Morales, D. R., Mullerova, H., Smeeth, L., Douglas, I. J., and Quint, J. K., “Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care”, Br J Gen Pract, vol. 68, pp. e775-e782, 2018.
J. G. Royle, Lanyon, P. C., Grainge, M. J., Abhishek, A., and Pearce, F. A., “Correction to: The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink”, Clin Rheumatol, vol. 37, p. 2601, 2018.
G. Moncrieff, Lied-Lied, A., Nelson, G., Holy, C. E., Weinstein, R., Wei, D., and Rowe, S., “Cost and effectiveness of prescribing emollient therapy for atopic eczema in UK primary care in children and adults: a large retrospective analysis of the Clinical Practice Research Datalink”, BMC Dermatol, vol. 18, p. 9, 2018.
S. Landis, Suruki, R., Maskell, J., Bonar, K., Hilton, E., and Compton, C., “Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink”, Copd, vol. 15, pp. 177-184, 2018.
N. C. Hazra, Rudisill, C., and Gulliford, M. C., “Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death?”, Eur J Health Econ, vol. 19, pp. 831-842, 2018.
D. Yu, Jordan, K. P., Snell, K. I. E., Riley, R. D., Bedson, J., Edwards, J. J., Mallen, C. D., Tan, V., Ukachukwu, V., Prieto-Alhambra, D., Walker, C., and Peat, G., “Development and validation of prediction models to estimate risk of primary total hip and knee replacements using data from the UK: two prospective open cohorts using the UK Clinical Practice Research Datalink”, Ann Rheum Dis, 2018.
D. Abrahami, Douros, A., Yin, H., Yu, O. H. Y., Renoux, C., Bitton, A., and Azoulay, L., “Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 360, p. k872, 2018.
J. Ride, Kasteridis, P., Gutacker, N., Kronenberg, C., Doran, T., Mason, A., Rice, N., Gravelle, H., Goddard, M., Kendrick, T., Siddiqi, N., Gilbody, S., Dare, C. R., Aylott, L., Williams, R., and Jacobs, R., “Do care plans and annual reviews of physical health influence unplanned hospital utilisation for people with serious mental illness? Analysis of linked longitudinal primary and secondary healthcare records in England”, BMJ Open, vol. 8, p. e023135, 2018.
A. Leite, Thomas, S. L., and Andrews, N. J., “Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink?”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 25-29, 2018.
A. Harshfield, Abel, G. A., Barclay, S., and Payne, R. A., “Do GPs accurately record date of death? A UK observational analysis”, BMJ Support Palliat Care, 2018.
P. Dhiman, Andersen, S., Vestergaard, P., Masud, T., and Qureshi, N., “Does bone mineral density improve the predictive accuracy of fracture risk assessment? A prospective cohort study in Northern Denmark”, BMJ Open, vol. 8, p. e018898, 2018.
A. Mehrabadi, Reynier, P., Platt, R. W., and Filion, K. B., “Domperidone for insufficient lactation in England 2002-2015: A drug utilization study with interrupted time series analysis”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 1316-1324, 2018.
J. E. Thistle, Petrick, J. L., Yang, B., Bradley, M. C., Graubard, B. I., and McGlynn, K. A., “Domperidone use and risk of primary liver cancer in the Clinical Practice Research Datalink”, Cancer Epidemiol, vol. 55, pp. 170-175, 2018.
Y. Tao and Fu, H., “Doubly robust estimation of the weighted average treatment effect for a target population”, Stat Med, 2018.
D. J. Humes, Abdul-Sultan, A., Walker, A. J., Ludvigsson, J. F., and West, J., “Duration and magnitude of postoperative risk of venous thromboembolism after planned inguinal hernia repair in men: a population-based cohort study”, Hernia, vol. 22, pp. 447-453, 2018.
C. Koshiaris, Van den Bruel, A., Oke, J. L., Nicholson, B. D., Shephard, E., Braddick, M., and Hamilton, W., “Early detection of multiple myeloma in primary care using blood tests: a case-control study in primary care”, Br J Gen Pract, vol. 68, pp. e586-e593, 2018.
H. A. Abenhaim, Tulandi, T., Wilchesky, M., Platt, R., Spence, A. R., Czuzoj-Shulman, N., and Suissa, S., “Effect of Cesarean Delivery on Long-term Risk of Small Bowel Obstruction”, Obstet Gynecol, vol. 131, pp. 354-359, 2018.
N. M. Davies, Taylor, G. M. J., Taylor, A. E., Jones, T., Martin, R. M., Munafo, M. R., Windmeijer, F., and Thomas, K. H., “The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records”, Addiction, vol. 113, pp. 1105-1116, 2018.
K. J. Roberts, Bannister, C. A., and Schrem, H., “Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study”, Pancreatology, 2018.
A. Cassell, Edwards, D., Harshfield, A., Rhodes, K., Brimicombe, J., Payne, R., and Griffin, S., “The epidemiology of multimorbidity in primary care: a retrospective cohort study”, Br J Gen Pract, vol. 68, pp. e245-e251, 2018.
M. Liang, Ye, T., and Fu, H., “Estimating individualized optimal combination therapies through outcome weighted deep learning algorithms”, Stat Med, vol. 37, pp. 3869-3886, 2018.
L. R. Vaz, Jones, M. J., Szatkowski, L., Tata, L. J., Petrou, S., and Coleman, T., “Estimating the health-care costs of children born to pregnant smokers in England: cohort study using primary and secondary health-care data”, Addiction, vol. 113, pp. 1305-1316, 2018.
H. Caspard, Steffey, A., Mallory, R. M., and Ambrose, C. S., “Evaluation of the safety of live attenuated influenza vaccine (LAIV) in children and adolescents with asthma and high-risk conditions: a population-based prospective cohort study conducted in England with the Clinical Practice Research Datalink”, BMJ Open, vol. 8, p. e023118, 2018.
C. I. Bloom, Nissen, F., Douglas, I. J., Smeeth, L., Cullinan, P., and Quint, J. K., “Exacerbation risk and characterisation of the UK's asthma population from infants to old age”, Thorax, vol. 73, pp. 313-320, 2018.
J. M. Gamble, Chibrikov, E., Midodzi, W. K., Twells, L. K., and Majumdar, S. R., “Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink”, BMJ Open, vol. 8, p. e023830, 2018.
K. Donegan, Owen, R., Bird, H., Burch, B., Smith, A., and Tregunno, P., “Exploring the Potential Routine Use of Electronic Healthcare Record Data to Strengthen Early Signal Assessment in UK Medicines Regulation: Proof-of-Concept Study”, Drug Saf, vol. 41, pp. 899-910, 2018.
R. M. Joseph, van Staa, T. P., Lunt, M., Abrahamowicz, M., and Dixon, W. G., “Exposure measurement error when assessing current glucocorticoid use using UK primary care electronic prescription data”, Pharmacoepidemiol Drug Saf, 2018.
J. Jackson, Lewis, N. V., Feder, G. S., Whiting, P., Jones, T., Macleod, J., and Redaniel, M. T., “Exposure to domestic violence and abuse and consultations for emergency contraception: nested case-control study in a UK primary care dataset”, Br J Gen Pract, 2018.
D. R. Morales, Flynn, R., Zhang, J., Trucco, E., Quint, J. K., and Zutis, K., “External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches”, Respir Med, vol. 138, pp. 150-155, 2018.
T. K. Mukhtar, Bankhead, C., Stevens, S., Perera, R., Holt, T. A., Salisbury, C., and Hobbs, F. R., “Factors associated with consultation rates in general practice in England, 2013-2014: a cross-sectional study”, Br J Gen Pract, vol. 68, pp. e370-e377, 2018.
C. I. Alatorre, Hoogwerf, B. J., Deeg, M. A., Nelson, D. R., Hunter, T. M., Ng, W. T., and Rekhter, M. D., “Factors associated with stroke, myocardial infarction, ischemic heart disease, unstable angina, or mortality in patients from real world clinical practice with newly-diagnosed type 2 diabetes and early glycemic control”, Curr Med Res Opin, vol. 34, pp. 337-343, 2018.
O. Moussa, Arhi, C., Ziprin, P., Darzi, A., Khan, O., and Purkayastha, S., “Fate of the metabolically healthy obese-is this term a misnomer? A study from the Clinical Practice Research Datalink”, Int J Obes (Lond), 2018.
M. Iwagami, Tomlinson, L. A., Mansfield, K. E., Douglas, I. J., Smeeth, L., and Nitsch, D., “Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population-based cohort study”, Br J Clin Pharmacol, vol. 84, pp. 2142-2151, 2018.
R. de Jong, Peeters, P., Burden, A. M., De Bruin, M. L., Haak, H. R., Masclee, A. A. M., de Vries, F., and Janssen-Heijnen, M. L. G., “Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK”, Cancer Epidemiol, vol. 54, pp. 104-111, 2018.
J. L. Hong, M. Funk, J., LoCasale, R., Dempster, S. E., Cole, S. R., Webster-Clark, M., Edwards, J. K., and Sturmer, T., “Generalizing Randomized Clinical Trial Results: Implementation and Challenges Related to Missing Data in the Target Population”, Am J Epidemiol, vol. 187, pp. 817-827, 2018.
A. Douros, Filion, K. B., Yin, H., Yu, O. H., Etminan, M., Udell, J. A., and Azoulay, L., “Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy”, Diabetes Care, vol. 41, pp. 2330-2338, 2018.
[Page last reviewed 6 June 2019]